medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2013, Número 3

<< Anterior

Ann Hepatol 2013; 12 (3)


Dendritic cells in NASH: Friend or foe?

Handa P, Kowdley KV

Idioma: Ingles.
Referencias bibliográficas: 14
Paginas: 508-509
Archivo PDF: 65.56 Kb.


FRAGMENTO

Sin resumen.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Farrell GC, van Rooyen D, Gan L, Chitturi S. NASH is an Inflammatory Disorder: Pathogenic, Prognostic and Therapeutic Implications. Gut Liver 2012; 6: 149-171.

  2. Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications. Cusi K. Gastroenterology 2012; 142: 711-25.

  3. Zhan YT, An W. Roles of liver innate immune cells in nonalcoholic fatty liver disease. World J Gastroenterol 2010; 16: 4652-60.

  4. Tosello-Trampont AC, Landes SG, Nguyen V, Novobrantseva TI, Hahn YS. Kupffer cells trigger nonalcoholic steatohepatitis development in diet-induced mouse model through tumor necrosis factor-á production. J Biol Chem 2012; 287: 40161-72.

  5. Radaeva S, Sun R, Jaruga B, Nguyen VT, Tian Z, Gao B. Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners. Gastroenterology 2006; 130: 435-52.

  6. Henning JR, Graffeo CS, Rehman A, Fallon NC, Zambirinis CP, Ochi A, Barilla R, et al. Dendritic cells limit fibro-inflammatory injury in NASH. Hepatology 2013. Doi: 10.1002/ hep.26267 [Epub ahead of print].

  7. Schmidt SV, Nino-Castro AC, Schultze JL. Regulatory dendritic cells: there is more than just immune activation. Front Immunol 2012; 3: 274.

  8. Liu K, Nussenzweig MC. Origin and development of dendritic cells. Immunol Rev 2010; 234: 45-54.

  9. Hespel C, Moser M. Role of inflammatory dendritic cells in innate and adaptive immunity. Eur J Immunol 2012; 42: 2535-43.

  10. Hebbard L, George J. Animal models of nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol 2011; 8: 35-44.

  11. Hume DA. Macrophages as APC and the dendritic cell myth. J Immunol 2008; 181: 5829-35.

  12. Bennett CL, Clausen BE. DC ablation in mice: promises, pitfalls, and challenges. Trends Immunol 2007; 28: 525-31.

  13. van Blijswijk J, Schraml BU, Reis e Sousa C. Advantages and limitations of mouse models to deplete dendritic cells. Eur J Immunol 2013; 43: 22-6.

  14. Tittel AP, Heuser C, Ohliger C, Llanto C, Yona S, Hämmerling GJ, Engel DR, et al. Functionally relevant neutrophilia in CD11c diphtheria toxin receptor transgenic mice. Nat Methods 2012; 9: 385-90.




2020     |     www.medigraphic.com